One of the primary advantages next-generation sequencing (NGS) provides over other methods of analysis is that it is an effective and high-throughput solution for screening multiple samples and detecting viruses without prior knowledge of an infectious agent. Among its core capabilities, NGS workflows can be used to detect SARS-CoV-2 virus, perform surveillance and epidemiological studies, track mutational changes in the virus, enable unbiased pathogen discovery, and analyze potential susceptibility and human response to SARS-CoV-2 infection.
Identifying SARS-CoV-2 Variants
Multiple SARS-CoV-2 variants are circulating globally, some of which are reported to spread more easily and faster than others. Now you can sequence 6,000 SARS-CoV-2 libraries in a single flow cell using the high-throughput NEXTFLEX® Variant-Seq™ SARS-CoV-2 workflow optimized to quickly, easily, and affordably identify all mutations, including the Delta Variant of Conceren (VOC), in a PCR-positive sample.